Articles dans des revues avec comité de lecture (97)
  1. 73. Burgers, W. A., Blanchon, L., Pradhan, S., De Launoit, Y., Kouzarides, T., & Fuks, F. (2007). Viral oncoproteins target the DNA methyltransferases. Oncogene, 26(11), 1650-1655. doi:10.1038/sj.onc.1209950
  2. 74. Hellebrekers, D. M. E. I., Castermans, K., Viré, E., Dings, R. P. M., Hoebers, N. T. H., Mayo, K. H., Oude Egbrink, M. G. A., Molema, G., Fuks, F., van Engeland, M., & Griffioen, A. W. (2006). Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications. Cancer research, 66(22), 10770-10777. doi:10.1158/0008-5472.CAN-06-1609
  3. 75. Bernard, D., Gil, J., Dumont, P., Rizzo, S., Monte, D., Quatannens, B., Hudson, D., Visakorpi, T., Fuks, F., & De Launoit, Y. (2006). The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growth. Oncogene, 25(9), 1358-1366. doi:10.1038/sj.onc.1209179
  4. 76. Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M. F., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., Bollen, M., Esteller, M., Di Croce, L., De Launoit, Y., & Fuks, F. (2006). The Polycomb group protein EZH2 directly controls DNA methylation. Nature (London), 439(7078), 871-874. doi:10.1038/nature04431
  5. 77. Hellebrekers, D. M. E. I., Jair, K.-W., Viré, E., Eguchi, S., Hoebers, N. T. H., Fraga, M. F., Esteller, M., Fuks, F., Baylin, S. B., van Engeland, M., & Griffioen, A. W. (2006). Angiostatic activity of DNA methyltransferase inhibitors. Molecular cancer therapeutics, 5(2), 467-475. doi:10.1158/1535-7163.MCT-05-0417
  6. 78. Fuks, F. (2006). The view from the biochemist: Comment on "Chromatin code, local non-equilibrium dynamics, and the emergence of transcription regulatory programs" by Arndt Benecke. The European Physical Journal E: Soft Matter and Biological Physics, 19, 367-369. doi:10.1140/epje/i2005-10066-x
  7. 79. Brenner, C., & Fuks, F. (2006). DNA methyltransferases: facts, clues, mysteries. Current topics in microbiology and immunology, 301, 45-66. doi:10.1007/3-540-31390-7_3
  8. 80. Fuks, F. (2005). DNA methylation and histone modifications: teaming up to silence genes. Current opinion in genetics & development, 15(5), 490-495. doi:10.1016/j.gde.2005.08.002
  9. 81. Brenner, C., Deplus, R., Didelot, C., Loriot, A., Viré, E., De Smet, C., Gutierrez, A., Danovi, D., Bernard, D., Boon, T., Pelicci, P. G., Amati, B., Kouzarides, T., De Launoit, Y., Di Croce, L., & Fuks, F. (2005). Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO journal, 24(2), 336-346. doi:10.1038/sj.emboj.7600509
  10. 82. Espada, J., Ballestar, E., Fraga, M. F., Villar-Garea, A., Juarranz, A., Stockert, J. C., Robertson, D., Fuks, F., & Esteller, M. (2004). Human DNA methyltransferase 1 is required for maintenance of the histone H3 modification pattern. The Journal of biological chemistry, 279(35), 37175-37184. doi:10.1074/jbc.M404842200
  11. 83. Laduron, S., Deplus, R., Zhou, S., Kholmanskikh, O., Godelaine, D., De Smet, C., Hayward, S. D., Fuks, F., Boon, T., & De Plaen, E. (2004). MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription. Nucleic acids research, 32(14), 4340-4350. doi:10.1093/nar/gkh735
  12. 84. Hughes-Davies, L., Huntsman, D., Ruas, M., Fuks, F., Bye, J., Chin, S.-F., Milner, J., Brown, L. A., Hsu, F., Gilks, B., Nielsen, T., Schulzer, M., Chia, S., Ragaz, J., Cahn, A., Linger, L., Ozdag, H., Cattaneo, E., Jordanova, E. S., Schuuring, E., Yu, D. S., Venkitaraman, A., Ponder, B., Doherty, A., Aparicio, S., Bentley, D., Theillet, C., Ponting, C. P., Caldas, C., & Kouzarides, T. (2003). EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. Cell, 115(5), 523-535.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 Suivant >>